Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$136K Sell
1,152
-1,814
-61% -$209K ﹤0.01% 663
2026
Q1
$354K Sell
2,966
-1,026
-26% -$135K ﹤0.01% 473
2025
Q4
$544K Sell
3,992
-101
-2% -$14.5K 0.01% 416
2025
Q3
$604K Buy
4,093
+327
+9% +$45.4K 0.01% 391
2025
Q2
$487K Buy
3,766
+1,553
+70% +$188K 0.01% 415
2025
Q1
$264K Buy
2,213
+11
+0.5% +$1.36K ﹤0.01% 478
2024
Q4
$255K Buy
2,202
+19
+0.9% +$2.4K ﹤0.01% 459
2024
Q3
$295K Sell
2,183
-10
-0.5% -$1.34K ﹤0.01% 451
2024
Q2
$297K Buy
2,193
+10
+0.5% +$1.36K ﹤0.01% 436
2024
Q1
$282K Sell
2,183
-131
-6% -$15.8K ﹤0.01% 436
2023
Q4
$265K Buy
2,314
+1,481
+178% +$148K ﹤0.01% 448
2023
Q3
$75.8K Hold
833
﹤0.01% 652
2023
Q2
$93.8K Sell
833
-3,008
-78% -$318K ﹤0.01% 623
2023
Q1
$402K Sell
3,841
-1,713
-31% -$179K 0.01% 413
2022
Q4
$614K Hold
5,554
0.01% 363
2022
Q3
$485K Buy
5,554
+2,163
+64% +$197K 0.01% 381
2022
Q2
$265K Hold
3,391
0.01% 470
2022
Q1
$289K Sell
3,391
-562
-14% -$53.8K 0.01% 475
2021
Q4
$474K Sell
3,953
-228
-5% -$28.3K 0.01% 410
2021
Q3
$517K Buy
4,181
+2,400
+135% +$309K 0.01% 389
2021
Q2
$214K Hold
1,781
﹤0.01% 520
2021
Q1
$187K Buy
1,781
+461
+35% +$46.7K ﹤0.01% 527
2020
Q4
$134K Sell
1,320
-4
-0.3% -$376 ﹤0.01% 542
2020
Q3
$111K Buy
1,324
+4
+0.3% +$311 ﹤0.01% 544
2020
Q2
$86K Buy
+1,320
New +$87.1K ﹤0.01% 565
2020
Q1
Sell
-300
Closed -$24K 1044
2019
Q4
$24K Buy
+300
New +$23.4K ﹤0.01% 757
2019
Q2
Sell
-360
Closed -$28K 1134
2019
Q1
$28K Buy
+360
New +$26.3K ﹤0.01% 643

Other funds holding XYL

Cullen/Frost Bankers's XYL Position: Q2 2026 in Review

Cullen/Frost Bankers reduced its Xylem (XYL) stake by 61% in Q2 2026, selling an estimated $209K and leaving 1,152 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Cullen/Frost Bankers first reported a position in XYL in Q1 2019 and has held it in 27 quarters since. The position peaked at $614K in Q4 2022. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Cullen/Frost Bankers held 1,152 shares of Xylem worth $136K as of Q2 2026.
  • Cullen/Frost Bankers sold 1,814 Xylem shares in Q2 2026, an estimated $209K.
  • Xylem made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #663 holding.
  • Cullen/Frost Bankers first reported a position in Xylem in Q1 2019 and has held it in 27 quarters since.
  • Cullen/Frost Bankers's Xylem position peaked at $614K in Q4 2022.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.